KURE — KraneShares MSCI All China Health Care Index ETF
Data updated: 2026-06-15
KURE — KraneShares MSCI All China Health Care Index ETF data: holdings, portfolio allocation, expenses, performance, cashflows, risk and SEC filings. China Health Care Equity · $80.42M AUM · 0.65% expense ratio · 12.9% 1-yr return. From SEC regulatory filings.
KURE Fund Overview
KURE — KraneShares MSCI All China Health Care Index ETF is a US ETF managed by Krane Shares Trust, categorised as China Health Care Equity. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.
- Type: US ETF
- Manager: Krane Shares Trust
- Category: China Health Care Equity
- Assets under management: $80.42M
- 1-year return: 12.9%
- Ticker: KURE
- SEC CIK: 0001547576
- SEC series ID: S000059796
- Share class ID: C000195635
KURE Holdings
Top 10 holdings of KraneShares MSCI All China Health Care Index ETF by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets |
|---|---|
| Innovent Biologics, Inc. | 8.69% |
| BeOne Medicines AG | 8.17% |
| Wuxi Biologics (cayman) Inc. | 6.63% |
| Akeso Inc | 5.74% |
| WuXi AppTec Co., Ltd. | 5.68% |
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 4.58% |
| Shenzhen Mindray Bio-Medical Electronics Co Ltd | 4.29% |
| Sino Biopharmaceutical Limited | 4.18% |
| Cspc Pharmaceutical Group Limited | 3.61% |
| Hansoh Pharmaceutical Group Company Limited | 3.59% |
KURE Portfolio Allocation
Asset-class allocation of KraneShares MSCI All China Health Care Index ETF by percentage of net assets, from the latest SEC N-PORT filing.
| Asset class | Allocation |
|---|---|
| Equity | 99.9% |
| Cash & Equivalents | 1.6% |
KURE Performance
Total returns for KURE (as of 2026-08-01), from SEC filings.
| Period | Total return |
|---|---|
| YTD | -1.3% |
| 1 year | 12.9% |
| 3 years (annualised) | -4.7% |
| 5 years (annualised) | -11.7% |
KURE Risk Information
Risk metrics for KURE, derived from monthly returns in SEC filings.
- 1-year volatility (annualised): 22.6%
KURE Costs and Fees
KURE costs about $65 per $10,000 invested per year in fund expenses.
- Net expense ratio: 0.65%
- Gross expense ratio: 0.79%
- Portfolio turnover: 77%
- Brokerage commissions: 9.42 bps of average net assets (SEC N-CEN)
KURE Cashflows
Over the 12 months to 2026-03, KraneShares MSCI All China Health Care Index ETF had net outflows of $15.01M, from monthly SEC N-PORT filings.
| Month | Net flow |
|---|---|
| 2026-03 | $0 |
| 2026-02 | $4.58M |
| 2026-01 | $0 |
| 2025-12 | −$1.93M |
| 2025-11 | −$7.71M |
| 2025-10 | −$5.63M |
KURE Debt Constituents
No individual debt constituents are reported in KraneShares MSCI All China Health Care Index ETF's latest SEC N-PORT filing.
KURE Prospectus and SEC Filings
Official KraneShares MSCI All China Health Care Index ETF filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.
Related Funds
Related funds tracked on ABC INVEST:
Data Sources
ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.